
USD
+$0.00
(+0.00%
)At Close (As of Nov 11, 2025)
$12.45B
Market Cap
8.24
P/E Ratio
8.71
EPS
$85.92
52 Week High
$60.70
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $4.6B |
| Total Revenue | $8.3B |
| Cost Of Revenue | $3.7B |
| Costof Goods And Services Sold | $3.7B |
| Operating Income | $1B |
| Selling General And Administrative | $2.8B |
| Research And Development | $775M |
| Operating Expenses | $3.6B |
| Investment Income Net | - |
| Net Interest Income | -$367M |
| Interest Income | - |
| Interest Expense | $367M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $555M |
| Income Before Tax | $605M |
| Income Tax Expense | $127M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $478M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $972M |
| Ebitda | $1.5B |
| Net Income | $479M |
| Field | Value (USD) |
|---|---|
| Total Assets | $14B |
| Total Current Assets | $3.2B |
| Cash And Cash Equivalents At Carrying Value | $762M |
| Cash And Short Term Investments | $762M |
| Inventory | $965M |
| Current Net Receivables | $1.2B |
| Total Non Current Assets | $11B |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $2.5B |
| Intangible Assets Excluding Goodwill | $2.5B |
| Goodwill | $6.4B |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $293M |
| Other Non Current Assets | - |
| Total Liabilities | $11B |
| Total Current Liabilities | $2.7B |
| Current Accounts Payable | $618M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $200M |
| Total Non Current Liabilities | $8.8B |
| Capital Lease Obligations | - |
| Long Term Debt | $7.8B |
| Current Long Term Debt | $200M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $8B |
| Other Current Liabilities | $1.2B |
| Other Non Current Liabilities | $410M |
| Total Shareholder Equity | $3B |
| Treasury Stock | - |
| Retained Earnings | $242M |
| Common Stock | $2M |
| Common Stock Shares Outstanding | $174M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $1.2B |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $555M |
| Capital Expenditures | $380M |
| Change In Receivables | - |
| Change In Inventory | -$132M |
| Profit Loss | - |
| Cashflow From Investment | -$380M |
| Cashflow From Financing | -$240M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $479M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $4.6B |
| Total Revenue | $8.3B |
| Cost Of Revenue | $3.7B |
| Costof Goods And Services Sold | $3.7B |
| Operating Income | $1B |
| Selling General And Administrative | $2.8B |
| Research And Development | $775M |
| Operating Expenses | $3.6B |
| Investment Income Net | - |
| Net Interest Income | -$367M |
| Interest Income | - |
| Interest Expense | $367M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $555M |
| Income Before Tax | $605M |
| Income Tax Expense | $127M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $478M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $972M |
| Ebitda | $1.5B |
| Net Income | $479M |
Sector: HEALTHCARE
Industry: MEDICAL INSTRUMENTS & SUPPLIES
Solventum Corporation, based in Saint Paul, Minnesota, is a dynamic healthcare company focused on developing, manufacturing, and commercializing innovative solutions tailored to meet critical customer and patient needs. With a robust portfolio that spans various healthcare sectors, Solventum leverages cutting-edge research and technology to enhance patient outcomes and drive operational efficiency. The company's commitment to quality and excellence positions it as a key player in the healthcare industry, attracting interest from institutional investors seeking growth opportunities in the evolving healthcare landscape.